Figure 8
Immunotherapy effect and drug sensitivity analysis using R software. (A–D) Differences in IPS among different risk groups in the four situations: negative immunoresponse to both PD-L1/PD-1 inhibitors and CTLA-4 inhibitors (A); positive immunoresponse to PD-L1/PD-1 inhibitors (B); positive immunoresponse to CTLA-4 inhibitors (C); positive immunoresponse to both PD-L1/PD-1 inhibitors and CTLA-4 inhibitors (D). (E–H) Differences in sensitivity of cisplatin (E), docetaxel (F), erlotinib (G), gefitinib (H) between high and low risk groups. (I) Spearman analysis between TIDE score and risk score. (J) Differences in TIDE score among different risk groups. The hollow diamond patterns in the violin diagram represent the IPS or TIDE score ensemble average.
